TROY, Va., Dec. 2, 2025 /PRNewswire/ — As Americans approach the holiday season, they will eat some of the largest meals of the year. Nutrition experts say this is the perfect time to...

The expansion underscores Merck’s commitment to invest more than $70 billion in U.S. research, development and capital projects RAHWAY, NJ, Oct. 20, 2025 – Merck (NYSE: MRK), known as MSD...

New manufacturing facility to be located near Charlottesville, in Albemarle County, Virginia will develop and manufacture a broader range of medicines including weight management, metabolic and cancer technologies Facility marks...

BUILT Biotechnologies, an emerging leader in DNA Manufacturing-as-a-Service, today announced its selection as an anchor company at the Commonwealth BioAccelerator, an initiative led by CvilleBioHub to strengthen Virginia’s biotechnology ecosystem....

Charlottesville medical data company Springbok Analytics has raised $5 million Series A round that includes participation from the NBA. Springbok said it will use to expand and innovate its AI-based...

TearSolutions, a Charlottesville biotech that is developing treatments for ocular surface diseases, has raised a $3 million Series B round. TearSolutions Inc., a Charlottesville biotech that is developing treatments for...

Codevelop and Commercialize Category-Defining Broad-Spectrum Bioinsecticide Charlottesville, VA and Limburgerhof, Germany — October 21, 2024 — AgroSpheres, a biotechnology leader in sustainable crop protection and crop health, and BASF, a...

CHARLOTTESVILLE, VA, September 30, 2024 – AgroSpheres Inc. (AGS), a biotechnology leader in sustainable crop protection and crop health, today announced the final close of a $37 million Series B funding round led by...

AMPEL BioSolutions is a precision medicine company commercializing a development pipeline of CLIA-certified gene expression tests for blood or tissue samples that provide clinical decision support.

CHARLOTTESVILLE, Va., Dec. 14, 2022 /PRNewswire/ — BrightSpec, Inc., a life science tools company commercializing Molecular Rotational Resonance (MRR) spectroscopy, announced today the closing of an $18.4 million Series C financing round, led by...